Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

As of last trade Siemens Healthineers AG (SHL:FRA) traded at 51.16, -11.37% below its 52-week high of 57.72, set on May 31, 2022.
52-week range
40.53Sep 23 202257.72May 31 2022
Short selling activity
Provided by S&P Global Market Intelligence
Previous close50.82
Average volume9.61k
Shares outstanding1.13bn
Free float281.33m
P/E (TTM)28.87
Market cap57.57bn EUR
EPS (TTM)1.77
Annual div (ADY)0.95
Annual div yield (ADY)1.87%
Div ex-dateFeb 16 2023
Div pay-dateFeb 20 2023
Data delayed at least 15 minutes, as of Mar 20 2023 10:05 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.